Sodium Iodide I 123 Capsule, Gelatin Coated
Product Images NDC 69945-601
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Iodide I 123 (NDC 69945-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Curium Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Graph 2 (Sodium Iodide I 123 Capsules 69945 2)
This text seems to show a table with two rows and seven columns. The first row has the sequential number '1' repeated three times in separate cells. The second row includes numbers representing time values that increase by 5, starting from 0 and ending at 30. The text at the top of the columns reads "Calibration Expiration Time" and "HOURS Time", respectively. It appears to be a chart created to track the calibration expiration time for a particular device.*
Display Panel A601co (Sodium Iodide I 123 Capsules 69945 3)
This is a prescription drug called "Sodium Iodide 1123 Capsules" manufactured by "Curum US LC". It is for oral administration only and must be handled only by qualified personnel. The drug must be stored in a container and kept at controlled room temperature (20°C to 25°C). The package insert should be read before use. The drug is radioactive and falls under the regulations of the Nuclear Regulatory Commission and state regulatory agencies. The details of the dosage and expiry date are also given.*
Display Panel A602co (Sodium Iodide I 123 Capsules 69945 4)
This is a description of a product called "Sodium iodide 1123 capsules" which is a diagnostic drug that must be handled by qualified personnel due to its radioactive nature. It is manufactured by Curum U LC and should be stored at a controlled room temperature between 20°to25°C (68°to 77°F). There is a warning on the package that the drug should be handled only by qualified personnel in conformity with regulations of the Nuclear Regulatory Commission or state regulatory agencies where applicable. The text also mentions the presence of a total Act MBa/cap (uCi/cap) and an expiration date. The package insert should be read for directions for use and it is for oral administration only. There is no information given about the purpose of the drug or what it is used to diagnose.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.